Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora

ABSTRACT

ConditionCOVID;SARS-CoV 2;Pneumonia, Viral;Coronavirus Infection

InterventionOther Oxygen-ozone therapy, probiotic supplementation and Standard of care;Dietary Supplement SivoMixx (200 billion);Drug Azithromycin;Drug hydroxychloroquine

Primary outcome:Delta in the number of patients requiring orotracheal intubation despite treatment

Criteria
Inclusion Criteria

- Age > 18 years

- Nasopharyngeal swab positive for COVID-19

- COVID-19 stages I - II - III (*1)

- Hospitalization in the Department of Infectious Diseases

Exclusion Criteria

- COVID-19 stages IV - V - VI (*1)

- Hospitalization in Intensive Care Units

- Pregnancy

- Glucose-6-phosphate dehydrogenase (G6PD) deficiency

- Patients who deny consent to the proposed treatment

- Inability to provide informed consent

- Contraindications to performing oxygen-ozone therapy

- hyperhomocysteinemia

- favism or thyroiditis

- coagulopathies

- neurodegenerative diseases

- angina (in particular Prinzmetal's angina) or with previous myocardial infarction

(*1) Compliant with indications published by

Italian Society of Anesthesia Analgesia Resuscitation and Intensive Care (SIAARTI).

Care pathway for the patient with COVID-19.

Section 2 - Recommendations for local management of the critically ill patient - Version 2

Available on
http//www.siaarti.it/SiteAssets/News/COVID19%20-%20documenti%20SIAARTI/Percorso%20COVID-19
%20-%20Sezione%202%20-%20Raccomandazioni%20per%20la%20gestione%20locale%20-%20Rev%202.0.pdf

Last accessed 20/04/2020

Posted on 26.03.2020

On page 2 of the previous document

"6 identified stages

- sick disease - mild COVID-19 (I stage)

- light pneumonia - mild COVID-19 (II stage)

- serious pneumonia - severe COVID-19 (III stage)

- Acute respiratory distress syndrome (ARDS) - critical COVID-19 (IV stage)

- sepsis - critical COVID-19 (V stage)

- septic shock - critical COVID-19 (VI stage)"